ARTICLE | Clinical News
Vestar Inc. regulatory update
January 16, 1995 8:00 AM UTC
Vestar Inc. (VSTR) The San Dimas, Calif., company filed an amendment to its NDA for DaunoXome liposomal daunorubicin to treat Kaposi's sarcoma. The amendment includes results and analysis of a Phase ...